Nautilus Biotechnology Inc (NAUT) — Long-term Investment Intensity
Nautilus Biotechnology Inc (NAUT) has a Long-term Investment Intensity of 18.4% as of September 2025. Long-term investments of $37.06 Million represent 18.4% of total assets of $200.91 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how resilient are Nautilus Biotechnology Inc's assets to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Nautilus Biotechnology Inc Long-term Investment Intensity (2021–2024)
This chart shows how Nautilus Biotechnology Inc's Long-term Investment Intensity has evolved across 4 annual periods from 2021 to 2024. As of September 2025, the intensity stands at 18.4%, reflecting long-term investments of $37.06 Million against total assets of $200.91 Million USD. For the complete balance sheet picture, see Nautilus Biotechnology Inc asset portfolio.
Annual Long-term Investment Intensity for Nautilus Biotechnology Inc (2021–2024)
The table below presents the year-by-year Long-term Investment Intensity for Nautilus Biotechnology Inc from 2021 to 2024, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read how much debt does Nautilus Biotechnology Inc carry for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 31.5% | $76.41 Million | $242.74 Million | ▲ +1.8 pp |
| 2023 | 29.7% | $90.65 Million | $305.56 Million | ▼ -7.2 pp |
| 2022 | 36.9% | $129.17 Million | $350.05 Million | ▲ +32.8 pp |
| 2021 | 4.1% | $16.37 Million | $398.45 Million | — |